ENVI's concession for clinical investigations of short-term high-risk devices
This article was originally published in Clinica
Executive Summary
When the European Parliament’s lead committee voted on the compromise amendments to the European Commission’s proposed medical devices Regulation on 25 September, there were few changes to the articles that most concern industry when compared with the same articles in the 13 September proposed compromise amendments that had been put forward by ENVI rapporteur Dagmar Roth Behrendt.